E-LIB Suche - Ergebnisse für: Zubairi, I.

1

Author Correction: Results of the phase IIa RADICAL trial o..:

Coombes, R. C. ; Badman, P. D. ; Lozano-Kuehne, J. P....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

2

Results of the phase IIa RADICAL trial of the FGFR inhibito..:

Coombes, R. C. ; Badman, P. D. ; Lozano-Kuehne, J. P....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

3

1907 CT staging in patients with sentinel or axillary lymph..:

Zubairi, I. ; Zaidi, M. ; Alhasso, A..
European Journal of Cancer. 51 (2015) - p. S301-S302 , 2015

Link: https://doi.org/10.1016/..

4

Optimization of concentration and exposure time of polytetr..:

Rahman, N F N N A ; Hashim, H ; Zubairi, S I
IOP Conference Series: Earth and Environmental Science. 1200 (2023) 1 - p. 012044 , 2023

Link: https://doi.org/10.1088/..

5

Production of Gummy Confection using Seeds Gum from Durio z..:

Kai, K Y ; Zubairi, S I ; Shaiful Hisham, I H...
IOP Conference Series: Materials Science and Engineering. 1232 (2022) 1 - p. 012005 , 2022

Link: https://doi.org/10.1088/..

6

Improving wood durability against G. Trabeum and C. versico..:

Lazim, Azwan Mat ; Azfaralariff, A. ; Azman, Imran...
Journal of the Taiwan Institute of Chemical Engineers. 115 (2020) - p. 242-250 , 2020

Link: https://doi.org/10.1016/..

7

Author Correction: Results of the phase IIa RADICAL trial o..:

Coombes, RC ; Badman, PD ; Lozano-Kuehne, JP...
Nature Communications. , 2023

Link: http://hdl.handle.net/10..

8

Author Correction:Results of the phase IIa RADICAL trial of..:

Coombes, R. C ; Badman, P. D ; Lozano-Kuehne, J. P...
https://research.vumc.nl/en/publications/b3ee0e28-5d1b-4b34-b1e8-b9b33e588db9. , 2023

Link: https://research.vumc.nl..

9

Results of the phase IIa RADICAL trial of the FGFR inhibito..:

Coombes, RC ; Badman, PD ; Lozano-Kuehne, JP...
https://www.repository.cam.ac.uk/handle/1810/338357. , 2022

Link: https://www.repository.c..

10

Results of the phase IIa RADICAL trial of the FGFR inhibito..:

Coombes, R. C ; Badman, P. D ; Lozano-Kuehne, J. P...
https://research.vumc.nl/en/publications/aafdd852-e2c6-4c4a-90c6-3c913d42b2ce. , 2022

Link: https://research.vumc.nl..

11

Results of the phase IIa RADICAL trial of the FGFR inhibito..:

Coombes, R.C ; Badman, P.D ; Lozano-Kuehne, J.P...
https://eprints.gla.ac.uk/272950/1/272950.pdf. , 2022

Link: https://eprints.gla.ac.u..

12

Results of the phase IIa RADICAL trial of the FGFR inhibito..:

Coombes, R. C ; Badman, P. D ; Lozano-Kuehne, J. P...
https://research.vumc.nl/en/publications/aafdd852-e2c6-4c4a-90c6-3c913d42b2ce. , 2022

Link: https://research.vumc.nl..

13

Phase 1 dose-finding and pharmacokinetic study of eribulin-..:

Evans, TRJ ; Dean, E ; Molife, LR...
British journal of cancer, 2019, 120 (4), pp. 379 - 386. , 2020

Link: https://repository.icr.a..

14

Phase 1 dose-finding and pharmacokinetic study of eribulin-..:

Evans, TRJ ; Dean, E ; Molife, LR...
https://discovery.ucl.ac.uk/id/eprint/10068274/1/163344.pdf. , 2019

Link: https://discovery.ucl.ac..

15

A phase 1b/2, open-label, dose-escalation, and dose-confirm..:

Twelves, C ; Anthoney, A ; Savulsky, CI...
https://eprints.whiterose.ac.uk/148290/1/s41416-018-0366-5.pdf. , 2019

Link: https://eprints.whiteros..